leadf
logo-loader
RNS
viewSynectics

Synectics PLC - Director/PDMR Shareholding

RNS Number : 6528U
Synectics PLC
30 July 2020
 

 

 

 

 

30 July 2020

 

 

Synectics plc

 

Director's/PDMR Dealings

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that on 30 July 2020 Paul Webb, Chief Executive Officer of the Company, and Iain Stringer, a PDMR of the Company, each purchased 5,000 ordinary shares of 20 pence each in the Company ("Ordinary Shares"), at 130 pence per share.

 

Following these purchases, the interests of Paul Webb and Iain Stringer in Ordinary Shares are as follows:

 

Name

Ordinary Shares Held

Interest in Ordinary Shares in Company Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

57,115

233,909

291,024

1.64%

Iain Stringer

12,210

10,000

22,210

0.12%

 

 

-ends-

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The group's expert engineering teams work in partnership with customers to create integrated product and technology platforms, proven in the most complex and demanding operating environments.

Find out more at www.synecticsplc.com.

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief Executive

David Bedford, Finance Director


email: info@synecticsplc.com

www.synecticsplc.com



Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks

 

 


Media enquiries:

Intelligent Conversation

 

Tel: +44 (0) 161 694 3979

Claire Evans

Email: claire@weareic.com

 


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEADXEDEAEEFA

Quick facts: Synectics

Price: 132.5

Market: AIM
Market Cap: £23.58 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE